Viewing Study NCT00449761


Ignite Creation Date: 2025-12-24 @ 12:31 PM
Ignite Modification Date: 2026-02-01 @ 5:36 PM
Study NCT ID: NCT00449761
Status: TERMINATED
Last Update Posted: 2021-07-15
First Post: 2007-03-20
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia, Myeloid, Chronic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Refractory View
None Chronic Myeloid View
None Leukemia View
None accelerated phase View
None blast phase (blast crisis) View
None adults View
None oral LBH589 View